Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Schmelz Hubertus, Director. Insider active across 1 company, notably Sangui Biotech International INC. Aggregated, 1 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €20k. Activity tracked since 13 October 2021. The latest transaction was filed on 13 October 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Hubertus Schmelz serves as a Director at Sangu Biotech International Inc. As a board member, he contributes to the governance of the company and strategic decision-making. Hubertus brings his expertise in the biopharmaceutical field to help Sangu achieve its objectives.